 Mona Abaza
Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Otolaryngology | 10 | 2021 | 108 | 2.730 |
Why?
| | Voice Disorders | 10 | 2023 | 23 | 1.740 |
Why?
| | Personnel Selection | 4 | 2019 | 91 | 1.210 |
Why?
| | Internship and Residency | 8 | 2019 | 1269 | 1.150 |
Why?
| | Laryngoscopy | 5 | 2023 | 121 | 0.790 |
Why?
| | Larynx | 4 | 2015 | 56 | 0.700 |
Why?
| | Physicians, Women | 1 | 2021 | 90 | 0.620 |
Why?
| | Learning | 1 | 2023 | 444 | 0.570 |
Why?
| | Leadership | 2 | 2021 | 402 | 0.520 |
Why?
| | Treatment Adherence and Compliance | 1 | 2017 | 27 | 0.510 |
Why?
| | Career Choice | 1 | 2018 | 235 | 0.470 |
Why?
| | Resilience, Psychological | 1 | 2018 | 150 | 0.460 |
Why?
| | Deglutition Disorders | 1 | 2017 | 154 | 0.450 |
Why?
| | Injections | 1 | 2015 | 199 | 0.430 |
Why?
| | Education, Medical | 1 | 2018 | 276 | 0.420 |
Why?
| | Voice | 2 | 2017 | 12 | 0.390 |
Why?
| | Simulation Training | 1 | 2015 | 136 | 0.380 |
Why?
| | Education, Medical, Undergraduate | 1 | 2016 | 208 | 0.380 |
Why?
| | Vocal Cords | 4 | 2006 | 27 | 0.350 |
Why?
| | Occupational Diseases | 2 | 2006 | 165 | 0.350 |
Why?
| | Patient Care Team | 1 | 2017 | 697 | 0.340 |
Why?
| | Voice Quality | 3 | 2023 | 23 | 0.340 |
Why?
| | Burnout, Professional | 1 | 2018 | 488 | 0.330 |
Why?
| | Hepatitis C | 2 | 2020 | 256 | 0.320 |
Why?
| | Carcinoma, Hepatocellular | 2 | 2020 | 373 | 0.300 |
Why?
| | Education, Medical, Graduate | 3 | 2019 | 562 | 0.270 |
Why?
| | Liver Neoplasms | 2 | 2020 | 777 | 0.250 |
Why?
| | Inhibin-beta Subunits | 1 | 2006 | 6 | 0.240 |
Why?
| | Activins | 1 | 2006 | 29 | 0.240 |
Why?
| | Schistosomiasis | 1 | 2006 | 50 | 0.230 |
Why?
| | Job Application | 2 | 2015 | 17 | 0.210 |
Why?
| | Laryngeal Muscles | 2 | 2023 | 10 | 0.210 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2006 | 317 | 0.200 |
Why?
| | Phonation | 1 | 2023 | 10 | 0.190 |
Why?
| | Palpation | 1 | 2023 | 15 | 0.190 |
Why?
| | Speech-Language Pathology | 2 | 2023 | 24 | 0.180 |
Why?
| | Postpoliomyelitis Syndrome | 1 | 2001 | 3 | 0.170 |
Why?
| | Humans | 27 | 2023 | 145783 | 0.170 |
Why?
| | Glypicans | 1 | 2020 | 11 | 0.160 |
Why?
| | Dipeptidyl Peptidase 4 | 1 | 2020 | 15 | 0.160 |
Why?
| | Neurofibromatosis 2 | 2 | 1998 | 4 | 0.160 |
Why?
| | Equipment Design | 2 | 2015 | 525 | 0.150 |
Why?
| | Disability Evaluation | 1 | 2000 | 311 | 0.140 |
Why?
| | Pilot Projects | 2 | 2019 | 1898 | 0.140 |
Why?
| | Otolaryngologists | 1 | 2017 | 13 | 0.130 |
Why?
| | United States | 4 | 2019 | 16126 | 0.120 |
Why?
| | Educational Status | 1 | 2019 | 470 | 0.120 |
Why?
| | Organizational Culture | 1 | 2018 | 162 | 0.120 |
Why?
| | Interviews as Topic | 1 | 2019 | 916 | 0.110 |
Why?
| | Psychoses, Substance-Induced | 2 | 2007 | 16 | 0.110 |
Why?
| | Competitive Behavior | 1 | 2015 | 43 | 0.110 |
Why?
| | Dysphonia | 1 | 2014 | 13 | 0.110 |
Why?
| | Speech Acoustics | 1 | 2014 | 11 | 0.110 |
Why?
| | Cell Division | 1 | 1996 | 757 | 0.110 |
Why?
| | Faculty, Medical | 1 | 2018 | 305 | 0.110 |
Why?
| | Clinical Clerkship | 1 | 2016 | 109 | 0.100 |
Why?
| | Female | 14 | 2023 | 79045 | 0.100 |
Why?
| | Program Evaluation | 1 | 2018 | 944 | 0.100 |
Why?
| | Egypt | 2 | 2020 | 13 | 0.100 |
Why?
| | Electromyography | 3 | 2007 | 419 | 0.100 |
Why?
| | School Admission Criteria | 1 | 2013 | 35 | 0.100 |
Why?
| | Attitude | 1 | 2015 | 259 | 0.100 |
Why?
| | Correspondence as Topic | 1 | 2012 | 16 | 0.090 |
Why?
| | Clinical Competence | 2 | 2019 | 1247 | 0.090 |
Why?
| | Educational Measurement | 1 | 2016 | 326 | 0.090 |
Why?
| | Male | 14 | 2023 | 73010 | 0.090 |
Why?
| | Societies, Medical | 1 | 2016 | 900 | 0.080 |
Why?
| | Writing | 1 | 2012 | 101 | 0.080 |
Why?
| | Students, Medical | 1 | 2016 | 378 | 0.080 |
Why?
| | Surgeons | 1 | 2015 | 340 | 0.080 |
Why?
| | Nasal Decongestants | 2 | 2007 | 9 | 0.080 |
Why?
| | Anti-Ulcer Agents | 2 | 2007 | 12 | 0.080 |
Why?
| | Histamine H1 Antagonists | 2 | 2007 | 24 | 0.080 |
Why?
| | Observer Variation | 2 | 2023 | 357 | 0.070 |
Why?
| | Biomedical Research | 1 | 2015 | 719 | 0.070 |
Why?
| | Vocal Cord Paralysis | 2 | 2005 | 27 | 0.060 |
Why?
| | Music | 1 | 2006 | 48 | 0.060 |
Why?
| | Analgesics | 1 | 2007 | 231 | 0.060 |
Why?
| | Reproducibility of Results | 3 | 2023 | 3418 | 0.060 |
Why?
| | Movement Disorders | 1 | 2005 | 69 | 0.050 |
Why?
| | Predictive Value of Tests | 2 | 2023 | 2123 | 0.050 |
Why?
| | Stroboscopy | 1 | 2023 | 8 | 0.050 |
Why?
| | Glucocorticoids | 1 | 2007 | 532 | 0.050 |
Why?
| | Vagus Nerve Diseases | 1 | 2002 | 1 | 0.050 |
Why?
| | Middle Aged | 8 | 2023 | 36309 | 0.050 |
Why?
| | Severity of Illness Index | 3 | 2014 | 2933 | 0.050 |
Why?
| | Adult | 7 | 2023 | 40881 | 0.040 |
Why?
| | Posture | 1 | 2023 | 197 | 0.040 |
Why?
| | Cough | 1 | 2002 | 124 | 0.040 |
Why?
| | Laryngeal Diseases | 1 | 2001 | 31 | 0.040 |
Why?
| | Amyloidosis | 1 | 2001 | 45 | 0.040 |
Why?
| | Myasthenia Gravis | 1 | 2001 | 24 | 0.040 |
Why?
| | Cicatrix | 1 | 2001 | 69 | 0.040 |
Why?
| | alpha-Fetoproteins | 1 | 2020 | 42 | 0.040 |
Why?
| | Gastroesophageal Reflux | 1 | 2002 | 237 | 0.040 |
Why?
| | Audiometry, Pure-Tone | 2 | 1998 | 33 | 0.040 |
Why?
| | Parkinson Disease | 1 | 2005 | 601 | 0.040 |
Why?
| | Hepacivirus | 1 | 2020 | 242 | 0.040 |
Why?
| | Drug Prescriptions | 1 | 2001 | 288 | 0.040 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2001 | 261 | 0.030 |
Why?
| | Ear Neoplasms | 1 | 1998 | 10 | 0.030 |
Why?
| | Neurilemmoma | 1 | 1998 | 25 | 0.030 |
Why?
| | Acute Disease | 1 | 2001 | 1036 | 0.030 |
Why?
| | Adipose Tissue | 1 | 2001 | 645 | 0.030 |
Why?
| | Stroke | 1 | 2005 | 1271 | 0.030 |
Why?
| | Aged | 5 | 2023 | 26217 | 0.030 |
Why?
| | Spinal Neoplasms | 1 | 1996 | 37 | 0.030 |
Why?
| | Speech Production Measurement | 1 | 2014 | 12 | 0.030 |
Why?
| | Hearing Loss | 1 | 1998 | 249 | 0.030 |
Why?
| | Follow-Up Studies | 3 | 2001 | 5428 | 0.030 |
Why?
| | Judgment | 1 | 2014 | 58 | 0.030 |
Why?
| | Area Under Curve | 1 | 2014 | 332 | 0.020 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2014 | 152 | 0.020 |
Why?
| | Biomarkers, Tumor | 1 | 2020 | 1329 | 0.020 |
Why?
| | Speech Perception | 1 | 2014 | 91 | 0.020 |
Why?
| | ROC Curve | 1 | 2014 | 618 | 0.020 |
Why?
| | Prospective Studies | 2 | 2014 | 8078 | 0.020 |
Why?
| | Biomarkers | 1 | 2020 | 4302 | 0.020 |
Why?
| | Age Factors | 1 | 1996 | 3346 | 0.020 |
Why?
| | Patient Selection | 1 | 2012 | 739 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 2 | 1998 | 3916 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2014 | 3634 | 0.020 |
Why?
| | Algorithms | 1 | 2014 | 1851 | 0.010 |
Why?
| | Young Adult | 1 | 2023 | 14254 | 0.010 |
Why?
| | Age Distribution | 1 | 2005 | 404 | 0.010 |
Why?
| | Sex Distribution | 1 | 2005 | 388 | 0.010 |
Why?
| | Risk Assessment | 2 | 2005 | 3752 | 0.010 |
Why?
| | Brain | 1 | 1996 | 2969 | 0.010 |
Why?
| | Cross-Sectional Studies | 1 | 2015 | 5925 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2015 | 6085 | 0.010 |
Why?
| | Hoarseness | 1 | 2001 | 4 | 0.010 |
Why?
| | Pyridostigmine Bromide | 1 | 2001 | 5 | 0.010 |
Why?
| | Otorhinolaryngologic Surgical Procedures | 1 | 2001 | 38 | 0.010 |
Why?
| | Cholinesterase Inhibitors | 1 | 2001 | 47 | 0.010 |
Why?
| | Medical History Taking | 1 | 2001 | 117 | 0.010 |
Why?
| | Biopsy, Needle | 1 | 2001 | 185 | 0.010 |
Why?
| | Injections, Intramuscular | 1 | 2001 | 146 | 0.010 |
Why?
| | Drug Therapy | 1 | 2001 | 84 | 0.010 |
Why?
| | Steroids | 1 | 2001 | 160 | 0.010 |
Why?
| | Drug Utilization | 1 | 2001 | 168 | 0.010 |
Why?
| | Transplantation, Autologous | 1 | 2001 | 301 | 0.010 |
Why?
| | Incidence | 1 | 2005 | 2934 | 0.010 |
Why?
| | Speech Reception Threshold Test | 1 | 1998 | 1 | 0.010 |
Why?
| | Diagnosis, Differential | 1 | 2002 | 1512 | 0.010 |
Why?
| | Reflex, Vestibulo-Ocular | 1 | 1998 | 31 | 0.010 |
Why?
| | Retrospective Studies | 3 | 2001 | 17330 | 0.010 |
Why?
| | Evoked Potentials, Auditory, Brain Stem | 1 | 1998 | 50 | 0.010 |
Why?
| | Anti-Inflammatory Agents | 1 | 2001 | 478 | 0.010 |
Why?
| | Prognosis | 1 | 2005 | 4330 | 0.010 |
Why?
| | Chronic Disease | 1 | 2002 | 1812 | 0.010 |
Why?
| | Adolescent | 1 | 1996 | 22577 | 0.010 |
Why?
| | Child | 1 | 1996 | 22740 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2005 | 8347 | 0.010 |
Why?
| | Practice Patterns, Physicians' | 1 | 2001 | 1372 | 0.010 |
Why?
| | Risk Factors | 1 | 2001 | 10919 | 0.000 |
Why?
| | Treatment Outcome | 1 | 2001 | 11794 | 0.000 |
Why?
|
|
Abaza's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|